30
/de/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512562
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Erstellen
Create a timeline
Public timelines
Library
FAQ

1 Jan 2013 Jahr - Ado-Trastuzumab Emtansine (T-DM1)

Beschreibung:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Zugefügt zum Band der Zeit:

Cancer

ByTrinity Ozias
14 Nov 2019

Datum:

1 Jan 2013 Jahr
Jetzt
~ 11 years ago
About & FeedbackVereinbarungPrivatheitBibliothek
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com